Cargando…
Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
BACKGROUND: Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death. METHO...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996348/ https://www.ncbi.nlm.nih.gov/pubmed/21080962 http://dx.doi.org/10.1186/1756-9966-29-148 |
_version_ | 1782193189731434496 |
---|---|
author | Franco-Molina, Moisés A Mendoza-Gamboa, Edgar Sierra-Rivera, Crystel A Gómez-Flores, Ricardo A Zapata-Benavides, Pablo Castillo-Tello, Paloma Alcocer-González, Juan Manuel Miranda-Hernández, Diana F Tamez-Guerra, Reyes S Rodríguez-Padilla, Cristina |
author_facet | Franco-Molina, Moisés A Mendoza-Gamboa, Edgar Sierra-Rivera, Crystel A Gómez-Flores, Ricardo A Zapata-Benavides, Pablo Castillo-Tello, Paloma Alcocer-González, Juan Manuel Miranda-Hernández, Diana F Tamez-Guerra, Reyes S Rodríguez-Padilla, Cristina |
author_sort | Franco-Molina, Moisés A |
collection | PubMed |
description | BACKGROUND: Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death. METHODS: MCF-7 breast cancer cells were treated with colloidal silver (ranged from 1.75 to 17.5 ng/mL) for 5 h at 37°C and 5% CO(2 )atmosphere. Cell Viability was evaluated by trypan blue exclusion method and the mechanism of cell death through detection of mono-oligonucleosomes using an ELISA kit and TUNEL assay. The production of NO, LDH, and Gpx, SOD, CAT, and Total antioxidant activities were evaluated by colorimetric assays. RESULTS: Colloidal silver had dose-dependent cytotoxic effect in MCF-7 breast cancer cells through induction of apoptosis, shown an LD(50 )(3.5 ng/mL) and LD(100 )(14 ng/mL) (*P < 0.05), significantly decreased LDH (*P < 0.05) and significantly increased SOD (*P < 0.05) activities. However, the NO production, and Gpx, CAT, and Total antioxidant activities were not affected in MCF-7 breast cancer cells. PBMC were not altered by colloidal silver. CONCLUSIONS: The present results showed that colloidal silver might be a potential alternative agent for human breast cancer therapy. |
format | Text |
id | pubmed-2996348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29963482010-12-03 Antitumor activity of colloidal silver on MCF-7 human breast cancer cells Franco-Molina, Moisés A Mendoza-Gamboa, Edgar Sierra-Rivera, Crystel A Gómez-Flores, Ricardo A Zapata-Benavides, Pablo Castillo-Tello, Paloma Alcocer-González, Juan Manuel Miranda-Hernández, Diana F Tamez-Guerra, Reyes S Rodríguez-Padilla, Cristina J Exp Clin Cancer Res Research BACKGROUND: Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic effects on MCF-7 breast cancer cells and its mechanism of cell death. METHODS: MCF-7 breast cancer cells were treated with colloidal silver (ranged from 1.75 to 17.5 ng/mL) for 5 h at 37°C and 5% CO(2 )atmosphere. Cell Viability was evaluated by trypan blue exclusion method and the mechanism of cell death through detection of mono-oligonucleosomes using an ELISA kit and TUNEL assay. The production of NO, LDH, and Gpx, SOD, CAT, and Total antioxidant activities were evaluated by colorimetric assays. RESULTS: Colloidal silver had dose-dependent cytotoxic effect in MCF-7 breast cancer cells through induction of apoptosis, shown an LD(50 )(3.5 ng/mL) and LD(100 )(14 ng/mL) (*P < 0.05), significantly decreased LDH (*P < 0.05) and significantly increased SOD (*P < 0.05) activities. However, the NO production, and Gpx, CAT, and Total antioxidant activities were not affected in MCF-7 breast cancer cells. PBMC were not altered by colloidal silver. CONCLUSIONS: The present results showed that colloidal silver might be a potential alternative agent for human breast cancer therapy. BioMed Central 2010-11-16 /pmc/articles/PMC2996348/ /pubmed/21080962 http://dx.doi.org/10.1186/1756-9966-29-148 Text en Copyright ©2010 Franco-Molina et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Franco-Molina, Moisés A Mendoza-Gamboa, Edgar Sierra-Rivera, Crystel A Gómez-Flores, Ricardo A Zapata-Benavides, Pablo Castillo-Tello, Paloma Alcocer-González, Juan Manuel Miranda-Hernández, Diana F Tamez-Guerra, Reyes S Rodríguez-Padilla, Cristina Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
title | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
title_full | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
title_fullStr | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
title_full_unstemmed | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
title_short | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
title_sort | antitumor activity of colloidal silver on mcf-7 human breast cancer cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996348/ https://www.ncbi.nlm.nih.gov/pubmed/21080962 http://dx.doi.org/10.1186/1756-9966-29-148 |
work_keys_str_mv | AT francomolinamoisesa antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT mendozagamboaedgar antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT sierrariveracrystela antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT gomezfloresricardoa antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT zapatabenavidespablo antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT castillotellopaloma antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT alcocergonzalezjuanmanuel antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT mirandahernandezdianaf antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT tamezguerrareyess antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells AT rodriguezpadillacristina antitumoractivityofcolloidalsilveronmcf7humanbreastcancercells |